Back to search

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

Data up to Jan 2025

Published1997
Citations1,200
References35

Total Citations Per Year

Abstract

References (35)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S

1974 • 3,686 citations

Graft-versus-leukemia reactions after bone marrow transplantation

1990 • 2,781 citations

Chronic graft-versus-host syndrome in man

1980 • 2,438 citations

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]

1995 • 2,026 citations

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1979 • 1,538 citations

Antileukemic Effect of Chronic Graft-versus-Host Disease

1981 • 1,112 citations

Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase

1988 • 887 citations

Regimen-related toxicity in patients undergoing bone marrow transplantation.

1988 • 876 citations

Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]

1989 • 623 citations

Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]

1989 • 448 citations

Identical-Twin Bone Marrow Transplants for Leukemia

1994 • 291 citations

Response to salvage therapy and survival after relapse in acute myelogenous leukemia.

1989 • 178 citations

Clinical toxicity and laboratory effects of granulocyte‐colony‐ stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures

1996 • 169 citations

Fludarabine and Arabinosylcytosine Therapy of Refractory and Relapsed Acute Myelogenous Leukemia

1993 • 159 citations

Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.

1996 • 157 citations

Leukemia relapse after allogeneic bone marrow transplantation: a review

1994 • 156 citations

Outcome After Allogeneic Bone Marrow Transplant for Leukemia in Older Adults

1993 • 153 citations

Bone marrow transplantation in patients aged 45 years and older

1986 • 150 citations

Metabolism and action of purine nucleoside analogs

1991 • 141 citations

ISCN 1985 : an international system for human cytogenetic nomenclature (1985) : report of the Standing Committee on Human Cytogenetic Nomenclature

1985 • 138 citations

USE OF DNA RESTRICTION FRAGMENT LENGTH POLYMORPHISMS TO DOCUMENT MARROW ENGRAFTMENT AND MIXED HEMATOPOIETIC CHIMERISM FOLLOWING BONE MARROW TRANSPLANTATION

1987 • 133 citations

Increasing Utilization of Allogeneic Bone Marrow Transplantation

1992 • 127 citations

International system for human cytogenetic nomenclature (ISCN)

1994 • 110 citations

Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).

1996 • 81 citations

Changing Trends in Allogeneic Bone Marrow Transplantation for Leukemia in the 1980s

1992 • 77 citations

Bone marrow transplantation for chronic myelogenous leukemia.

1995 • 69 citations

Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.

1996 • 63 citations

Changes in blood counts after the administration of granulocyte‐colony‐ stimulating factor and the collection of peripheral blood stem cells from healthy donors

1996 • 53 citations

Bone marrow transplantation for hematologic malignancies in patients aged 30 years or older.

1986 • 35 citations

Cladribine (2-chloro-deoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro

1993 • 27 citations

Bone marrow transplantation for chronic myelogenous leukemia [letter; comment]

1994 • 18 citations

Fludarabine phosphate and 2-chlorodeoxyadenosine: immunosuppressive DNA synthesis inhibitors with potential application in islet allo- and xenotransplantation.

1995 • 11 citations

Bone marrow transplantation in patients aged 45 years and older

1986 • 6 citations

Cited By (0)

No citing papers found in database

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing… (1997) – Blood | Metascience Observatory Explorer